Optimizing poly (ADP‐ribose) polymerase inhibition through combined epigenetic and immunotherapy

Triple‐negative breast cancer (TNBC) is an aggressive breast cancer subtype with poor survival outcomes. Currently, there are no targeted therapies available for TNBCs despite remarkable progress in targeted and immune‐directed therapies for other solid organ malignancies. Poly (ADP‐ribose) polymera...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasanna, Thiru, Wu, Fan, Khanna, Kum Kum, Yip, Desmond, Malik, Laeeq, Dahlstrom, Jane E., Rao, Sudha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215877/
https://www.ncbi.nlm.nih.gov/pubmed/30230653
http://dx.doi.org/10.1111/cas.13799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215877/
https://www.ncbi.nlm.nih.gov/pubmed/30230653
http://dx.doi.org/10.1111/cas.13799

Ejemplares similares